HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe
20.02.2019
Europe is increasingly described as the region in the world with the least confidence in vaccination, and particularly in the safety of vaccines. The aim of this systematic literature review was to gather and summarise all peer-reviewed and grey literature published about determinants of Human Papillomavirus (HPV) vaccine hesitancy in Europe.
Visit websiteHPV World: HPV Vaccine: It Is Not Just a Girl Thing
13.02.2019
It is astonishing that a safe, effective, and widely accessible cancer-preventing vaccine is not being widely used! This begs the question-- why is the US not aggressively vaccinating its young men when we know that following the 2018 guidelines would lead to a 62-82% reduction disease burden, and a 22-27% reduction in cancers in males within 30 years?
Visit websiteHPV World: Adolescent male vaccination in the United Kingdom- a victory for equality
13.01.2019
The JCVI recommends implementation of vaccine programmes based on the issue of cost-effectiveness within the publiclyfunded NHS setting. Until July 2018, the main argument for not offering the vaccine to boys was that high uptake in girls (approximately 88% since 2008) confers significant herd protection to unvaccinated boys, and that offering vaccine to boys was therefore cost-ineffective. However, the argument not to have a gender-neutral programme is flawed several-fold.
Visit websiteEngaging parents around vaccine confidence: proceedings from the National HPV Vaccination Roundtable meetings.
05.10.2018
HPV vaccine uptake remains below national goals in the US, driven in part by parental uncertainty about the vaccine fueled by negative stories on social media and other information platforms. To identify opportunities for mobilizing parents to increase HPV vaccination uptake, the National HPV Vaccination Roundtable and Vaccinate Adolescents Against Cancers program convened two national meetings in 2016 at the American Cancer Society.
Visit websiteHPV immunization programs: ensuring their sustainability and resilience
23.08.2018
Since May 2018, Human Papillomavirus (HPV) immunization programs have been introduced in 80 countries, areas or territories using a variety of strategies. The HPV Prevention and Control Board has organized four technical and country meetings where international and local experts exchanged lessons learnt and experiences in order to strengthen countries’ efforts to secure HPV prevention and control.
Visit websiteRapid response to HPV vaccination crisis in Ireland
26.05.2018
Fighting vaccine misinformation and increasing vaccination uptake in Ireland.
Visit websiteKnowledge and acceptance of human papillomavirus (HPV) and HPV vaccination in adolescent boys worldwide: A systematic review
13.12.2016
To determine HPV and HPV vaccine awareness, knowledge and acceptance in male adolescents worldwide.
Visit website
